Title:
USE OF ANTI-EGFR ANTIBODY
Document Type and Number:
WIPO Patent Application WO/2023/138066
Kind Code:
A1
Abstract:
Provided in the present invention is the use of an anti-EGFR antibody in the preparation of a drug for preventing and/or treating diseases related to ocular angiogenesis.
Inventors:
LUO DELUN (CN)
LIU JINNAN (CN)
LUO DIXIANG (CN)
PENG HONGWEI (CN)
LIU JINNAN (CN)
LUO DIXIANG (CN)
PENG HONGWEI (CN)
Application Number:
PCT/CN2022/117106
Publication Date:
July 27, 2023
Filing Date:
September 05, 2022
Export Citation:
Assignee:
JINGZE PHARMA HEFEI CO LTD (CN)
SHANGHAI JINGZE PHARMA CO LTD (CN)
SHANGHAI JINGZE PHARMA CO LTD (CN)
International Classes:
A61K39/395; A61P9/10; A61P27/02
Foreign References:
| CN114652826A | 2022-06-24 | |||
| US20200138914A1 | 2020-05-07 | |||
| US20080145406A1 | 2008-06-19 | |||
| CN1886118A | 2006-12-27 | |||
| US20050043410A1 | 2005-02-24 | |||
| US20060035893A1 | 2006-02-16 | |||
| JP2014141481A | 2014-08-07 |
Attorney, Agent or Firm:
LECOME INTELLECTUAL PROPERTY AGENT LTD. (CN)
Download PDF:
Previous Patent: FOUR-WAY SEAMLESS VEHICLE SEAT LEG SUPPORTING DEVICE
Next Patent: MOVABLE ELECTRIC TOOTHBRUSH
Next Patent: MOVABLE ELECTRIC TOOTHBRUSH